<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-molecules-26-00224">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>I.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>I.S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.S.</given-names>
   </name>
  </person-group>
  <article-title>2′′, 4′′-
   <italic>O</italic>-diacetylquercitrin, a novel advanced glycation end-product formation and aldose reductase inhibitor from 
   <italic>Melastoma sanguineum</italic>
  </article-title>
  <source>Chem. Pharm. Bull.</source>
  <year>2013</year>
  <volume>61</volume>
  <fpage>662</fpage>
  <lpage>665</lpage>
  <pub-id pub-id-type="doi">10.1248/cpb.c12-00877</pub-id>
 </element-citation>
</ref>
